Literature DB >> 1652174

Genetics of colon cancer.

D J Ahnen1.   

Abstract

Strikingly rapid advances in the identification of genetic events that are important in colonic carcinogenesis have been made in the past several years. Specific inherited (adenomatous polyposis coli gene) and acquired (ras gene point mutations; c-myc gene amplification; allelic deletion at specific sites on chromosomes 5, 17, and 18) genetic abnormalities appear to be capable of mediating steps in the progression from normal to malignant colonic mucosa. Understanding these genetic factors and how they influence cellular function will have a profound effect on medical practice. High-risk populations will be (and are being) identified by genetic markers, thus allowing prevention and screening to be more precisely targeted to the population at risk; intervention strategies will be designed on the basis of the known cellular defects of neoplastic colonic mucosa; and new molecular preventive and therapeutic approaches can be developed.

Entities:  

Mesh:

Year:  1991        PMID: 1652174      PMCID: PMC1002870     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  42 in total

1.  Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli.

Authors:  M Okamoto; M Sasaki; K Sugio; C Sato; T Iwama; T Ikeuchi; A Tonomura; T Sasazuki; M Miyaki
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

2.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

3.  Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers.

Authors:  L A Cannon-Albright; M H Skolnick; D T Bishop; R G Lee; R W Burt
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

4.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies.

Authors:  H T Lynch; G S Schuelke; W J Kimberling; W A Albano; J F Lynch; K A Biscone; M L Lipkin; E E Deschner; Y B Mikol; A A Sandberg
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

5.  The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma.

Authors:  N A Scott; L M Rainwater; H S Wieand; L H Weiland; J H Pemberton; R W Beart; M M Lieber
Journal:  Dis Colon Rectum       Date:  1987-07       Impact factor: 4.585

Review 6.  The ras gene family and human carcinogenesis.

Authors:  J L Bos
Journal:  Mutat Res       Date:  1988-05       Impact factor: 2.433

7.  Tumor DNA content in the prognosis of colorectal carcinoma.

Authors:  W Kokal; K Sheibani; J Terz; J R Harada
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

8.  Close linkage of a highly polymorphic marker (D5S37) to familial adenomatous polyposis (FAP) and confirmation of FAP localization on chromosome 5q21-q22.

Authors:  P Meera Khan; C M Tops; M vd Broek; C Breukel; J T Wijnen; M Oldenburg; J vd Bos; I S van Leeuwen-Cornelisse; H F Vasen; G Griffioen
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

9.  Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.

Authors:  J Yokota; T Yamamoto; K Toyoshima; M Terada; T Sugimura; H Battifora; M J Cline
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

10.  Oncogene alterations in primary human colon tumors.

Authors:  R J Alexander; J N Buxbaum; R F Raicht
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.